Screener
Amylyx Pharmaceuticals, Inc. AMLX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (45,693) | (42,857) | (89,472) | (80,660) |
| Other income, net: | ||||
| Interest income | 2,323 | 1,960 | 4,893 | 4,191 |
| Other expense, net | (53) | (546) | (128) | (881) |
| Total other income, net | 2,270 | 1,414 | 4,765 | 3,310 |
| Net loss | $(43,423) | $(41,443) | $(84,707) | $(77,350) |
| Net loss per share — basic and diluted | $(0.39) | $(0.46) | $(0.76) | $(0.88) |
| Weighted-average shares used in computing net loss per share — basic and diluted | 111,196,883 | 89,138,568 | 110,881,872 | 87,427,345 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s EPS (basic)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported EPS (basic) of -$0.39 in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s EPS (basic) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s EPS (basic) increased by 15.2% year-over-year, from -$0.46 to -$0.39.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s EPS (basic) has grown at a -41.8% compound annual growth rate (CAGR), from -$13.35 to -$1.53.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude